- Home
- RES vs AUPH Comparison
RES vs AUPH Comparison
Compare RES & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RES
- AUPH
- Stock Information
- Founded
- RES 1984
- AUPH 1993
- Country
- RES United States
- AUPH Canada
- Employees
- RES N/A
- AUPH N/A
- Industry
- RES Oilfield Services/Equipment
- AUPH Biotechnology: Pharmaceutical Preparations
- Sector
- RES Energy
- AUPH Health Care
- Exchange
- RES Nasdaq
- AUPH Nasdaq
- Market Cap
- RES 1.1B
- AUPH 999.8M
- IPO Year
- RES N/A
- AUPH 1999
- Fundamental
- Price
- RES $5.03
- AUPH $7.75
- Analyst Decision
- RES Hold
- AUPH Strong Buy
- Analyst Count
- RES 3
- AUPH 2
- Target Price
- RES $5.75
- AUPH $11.50
- AVG Volume (30 Days)
- RES 2.2M
- AUPH 1.3M
- Earning Date
- RES 04-24-2025
- AUPH 05-01-2025
- Dividend Yield
- RES 3.34%
- AUPH N/A
- EPS Growth
- RES N/A
- AUPH N/A
- EPS
- RES 0.43
- AUPH 0.04
- Revenue
- RES $1,414,999,000.00
- AUPH $235,133,000.00
- Revenue This Year
- RES $0.07
- AUPH $11.86
- Revenue Next Year
- RES $9.25
- AUPH $24.96
- P/E Ratio
- RES $11.83
- AUPH $193.75
- Revenue Growth
- RES N/A
- AUPH 33.97
- 52 Week Low
- RES $4.10
- AUPH $4.71
- 52 Week High
- RES $8.14
- AUPH $10.67
- Technical
- Relative Strength Index (RSI)
- RES 48.09
- AUPH 46.63
- Support Level
- RES $4.18
- AUPH $7.59
- Resistance Level
- RES $4.96
- AUPH $7.83
- Average True Range (ATR)
- RES 0.34
- AUPH 0.35
- MACD
- RES 0.02
- AUPH -0.02
- Stochastic Oscillator
- RES 56.36
- AUPH 65.84
About RES RPC Inc.
RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.